Edition:
United States

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

71.23USD
16 Jan 2018
Change (% chg)

$-0.50 (-0.70%)
Prev Close
$71.73
Open
$72.02
Day's High
$72.47
Day's Low
$71.08
Volume
427,309
Avg. Vol
503,190
52-wk High
$72.47
52-wk Low
$47.05

Select another date:

Tue, Jan 9 2018

BRIEF-Agilent Expands Cell Analysis Portfolio With Acquisition Of Luxcel Biosciences

* AGILENT EXPANDS CELL ANALYSIS PORTFOLIO WITH ACQUISITION OF LUXCEL BIOSCIENCES

BRIEF-Agilent Technologies Q4 non-gaap earnings per share $0.67

* Agilent Technologies reports fourth-quarter fiscal year 2017 financial results

BRIEF-Agilent technologies increases cash dividend to 14.9 cents per share

* Agilent technologies increases cash dividend to 14.9 cents per share Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies receives expanded FDA approval for Dako PD-L1 IHC 22C3 pharmDx

* Agilent Technologies receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 pharmDx companion diagnostic in gastric or gastroesophageal junction (GEJ) cancer Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies announces sponsorship deal with LabCentral

* Announced platinum sponsorship agreement with LabCentral, co to equip LabCentral's shared laboratory workspace with co's technology​

BRIEF-Agilent announces expanded use of cancer diagnostic in U.S.

* Says ‍FDA approved cancer diagnostic for use in cases of UC and of Squamous Cell Carcinoma of head & neck​ Source text for Eikon: Further company coverage:

BRIEF-AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

* AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

BRIEF-Agilent Technologies files lawsuit against Shanghai Echrom Electronic and former employees

* FILED A CIVIL LAWSUIT AGAINST SHANGHAI ECHROM ELECTRONIC TECHNOLOGY CO LTD AND SEVERAL FORMER EMPLOYEES OF AGILENT

BRIEF-Agilent Technologies reports Q3 non-GAAP earnings per share of $0.59

* Agilent Technologies reports third-quarter fiscal year 2017 financial results

BRIEF-Agilent acquires Next Generation Sequencing IP portfolio

* Agilent acquires powerful Next Generation Sequencing IP portfolio

Select another date: